VANGUARD GROUP INC - COGNITION THERAPEUTICS INC ownership

COGNITION THERAPEUTICS INC's ticker is and the CUSIP is 19243B102. A total of 21 filers reported holding COGNITION THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of COGNITION THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$989,130
-19.1%
686,896
+2.8%
0.00%
Q2 2023$1,223,218
-4.0%
668,425
+3.9%
0.00%
Q1 2023$1,273,912
+11.3%
643,390
+18.1%
0.00%
Q4 2022$1,144,267
+50.2%
544,889
+35.8%
0.00%
Q3 2022$762,000
+408.0%
401,203
+465.7%
0.00%
Q2 2022$150,000
-6.8%
70,920
+21.0%
0.00%
Q1 2022$161,000
-56.6%
58,596
+0.0%
0.00%
Q4 2021$371,00058,5790.00%
Other shareholders
COGNITION THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Prosight Management, LP 240,080$660,0000.43%
P.A.W. CAPITAL CORP 120,000$330,0000.34%
Worth Venture Partners, LLC 175,366$473,0000.22%
AMERICAN FINANCIAL GROUP INC 205,000$564,0000.17%
APOGEM CAPITAL LLC 17,667$49,0000.03%
Diligent Investors, LLC 30,520$84,0000.02%
Nantahala Capital Management 196,402$540,0000.02%
Voss Capital, LLC 26,439$71,0000.02%
B. Riley Financial, Inc. 30,904$85,0000.02%
Rock Creek Group, LP 26,439$71,0000.01%
View complete list of COGNITION THERAPEUTICS INC shareholders